製品の概要

  • 製品名Anti-Cardiac Troponin I antibody [19C7]
    Cardiac Troponin I 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [19C7] to Cardiac Troponin I
  • 特異性No cross-reaction with skeletal muscle Troponin I
  • アプリケーション適用あり: WB, Sandwich ELISAmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Chicken, Xenopus laevis
  • 免疫原

    Synthetic peptide:

    ISASRKLQL

    , corresponding to amino acids 41-49 of Human Cardiac Troponin I

  • エピトープRecognises an epitope included within aa 41-49

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab92408 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use at an assay dependent concentration. Predicted molecular weight: 24 kDa.
Sandwich ELISA Use at an assay dependent concentration. Can be paired for Sandwich ELISA with Mouse monoclonal [4C2] to Cardiac Troponin I (ab10231) and Mouse monoclonal [16A11] to Cardiac Troponin I (HRP) (ab24460).

Recommended pairs for quantitative sandwich immunoassay (capture-detection):
ab92408 – ab24460, ab10231 – ab92408

ターゲット情報

  • 機能Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity.
  • 関連疾患Defects in TNNI3 are the cause of cardiomyopathy familial hypertrophic type 7 (CMH7) [MIM:613690]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
    Defects in TNNI3 are the cause of cardiomyopathy familial restrictive type 1 (RCM1) [MIM:115210]. RCM1 is an heart muscle disorder characterized by impaired filling of the ventricles with reduced diastolic volume, in the presence of normal or near normal wall thickness and systolic function.
    Defects in TNNI3 are the cause of cardiomyopathy dilated type 2A (CMD2A) [MIM:611880]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
    Defects in TNNI3 are the cause of cardiomyopathy dilated type 1FF (CMD1FF) [MIM:613286]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
  • 配列類似性Belongs to the troponin I family.
  • Information by UniProt
  • 参照データベース
    • 別名
      • cardiac muscle antibody
      • Cardiac troponin I antibody
      • cardiomyopathy, dilated 2A (autosomal recessive) antibody
      • Cardiomyopathy, familial hypertrophic, 7, included antibody
      • CMD1FF antibody
      • CMD2A antibody
      • CMH7 antibody
      • cTnI antibody
      • Familial hypertrophic cardiomyopathy 7 antibody
      • MGC116817 antibody
      • RCM1 antibody
      • Tn1 antibody
      • Tni antibody
      • TNN I3 antibody
      • TNNC 1 antibody
      • TNNC1 antibody
      • TNNI3 antibody
      • TNNI3_HUMAN antibody
      • Troponin I antibody
      • Troponin I cardiac antibody
      • Troponin I cardiac muscle antibody
      • Troponin I cardiac muscle isoform antibody
      • Troponin I type 3 cardiac antibody
      • troponin I, cardiac 3 antibody
      • TroponinI antibody
      • Ttroponin I type 3 (cardiac) antibody
      see all

    Anti-Cardiac Troponin I antibody [19C7] (ab92408) 使用論文

    This product has been referenced in:
    • Clause KC  et al. Developing cardiac and skeletal muscle share fast-skeletal myosin heavy chain and cardiac troponin-I expression. PLoS One 7:e40725 (2012). WB, IHC (PFA fixed) . Read more (PubMed: 22808244) »

    See 1 Publication for this product

    Product Wall

    Application Immunocytochemistry/ Immunofluorescence
    Sample Human Cell (iPSC-derived cardiomyocytes)
    Permeabilization Yes - 10 minutes in 0.2% Triton X-100
    Specification iPSC-derived cardiomyocytes
    Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 21°C
    Fixative Paraformaldehyde
    Username

    Mr. Mick Wauchope

    Verified customer

    投稿 Mar 23 2016

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"